Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001653477-25-000070
Filing Date
2025-05-05
Accepted
2025-05-05 17:51:23
Documents
6
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1746481875.html 4  
1 FORM 4 wk-form4_1746481875.xml 4 3637
2 EX-24.1 ngvt_poax-xedgarxnexthoe.htm EX-24.1 9450
3 ngvt_poax-xedgarxnexthoe001.jpg GRAPHIC 251263
4 ngvt_poax-xedgarxnexthoe002.jpg GRAPHIC 227003
5 ngvt_poax-xedgarxnexthoe003.jpg GRAPHIC 45385
6 ngvt_poax-xedgarxnexthoe004.jpg GRAPHIC 60849
  Complete submission text file 0001653477-25-000070.txt   820080
Mailing Address C/O CURTISS-WRIGHT CORPORATION 130 HARBOUR PLACE DRIVE, SUITE 300 DAVIDSON NC 28036
Business Address
Hoechner Bruce D. (Reporting) CIK: 0001531814 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37586 | Film No.: 25914400

Mailing Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405
Business Address 4920 O'HEAR AVENUE SUITE 400 NORTH CHARLESTON SC 29405 8437402300
Ingevity Corp (Issuer) CIK: 0001653477 (see all company filings)

EIN.: 474027764 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)